Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Apr 21, 2017; 23(15): 2757-2762
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2757
Figure 1
Figure 1 Kaplan-Meier analysis of overall survival. A: Among 1349 patients, the survival time of stage IB and IIA patients had no significant difference (P > 0.05); B: For both stage IB and IIA, death risk was lower in patients aged ≤ 65 yr than those aged > 65 yr.